JA2 WP5 – Applying the HTA Core Model for Rapid Assessment for national adaptation and reporting
Objectives
- To test the capacity of national HTA bodies to produce structured core HTA information (full core/rapid HTAs) together and apply it in national context (including collection of data on costs and overall efficiency of the production in the network)
- To implement, pilot and further develop models and tools as well as production processes to support collaborative production of core HTA information with reinforced secretariat and coordination function
- To develop and test a methodological basis for European cooperation on HTA including guidelines for distinct methodological issues and quality improvement of evidence generation for HTA.
Deliverables
- Pilot rapid assessments
Milestone
- Coordinating and supporting the joint pilots of rapid assessments of pharmaceuticals (strand A) and non-pharmaceuticals (strand B), on a quarterly basis during the first year
- Final rapid model for relative effectiveness of pharmaceuticals and rapid core model for non-pharmaceutical interventions (in cooperation with WP7).
Partners
Lead Partner
ZIN
National Health Care Institute
(Zorginstituut Nederland)
Eekholt 4
NL-112XH Diemen
Netherlands
Telephone: +31 207979057
Fax: +31 (020) 797 8500
http://www.zorginstituutnederland.nl/
Co-Lead Partner
Associated Partners
AAZ, Agenas, AOTMiT, AIFA, GOG, DEFACTUM (formerly CFK), DPA/MoH Malta, FIMEA, NIPN, HAS, HIQA, HVB, INFARMED, IQWIG, AETS-ISCIII, KCE, MoH Cyprus, MoH Czech, NVD, NIJZ, NIPHNO (formerly NOKC), Veneto/CRUF, THL, VASPVT
Collaborating partners
UCSC GEMELLI, AETSA, AQuAS, AVALIA-T, CHIF, CMSS, Danube University Krems, DGFPS MSPSI, HIS, RIZIV-INAMI, KDTD, KORA, Medical Valley – EMN, MU Sofia, NC HTA, NCPE, NCPRMP, Osteba, SAGEM, SESCS, SMCA, SNHTA, TÜBİTAK-TÜSSİDE<
